Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, December 28, 2014
Technology Networks
 
Register | Sign in
Home Page > Videos > Biosimilars and the US-legislation: Analytical and Clinical Challenges
  Videos

Return

Biosimilars and the US-legislation: Analytical and Clinical Challenges
Pharmanet Consulting

Recent legislation in the US provides a path forward for the licensure of biosimilar proteins; this legislation also allows for the interchangeability of the biosimilar with its reference product. This talk will emphasize some of the analytical and clinical challenges in demonstrating the “highly similar” nature of the biosimilar candidate and reference product, particularly for more complex proteins, such as the monoclonal antibodies.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
How to Achieve High-Speed, High-Resolution Glycan Mapping for mAb Characterization
The full characterization of biotherapeutics is required by regulatory authorities as properties such as safety, efficacy and the serum half-life of therapeutic proteins can be affected by differences in their glycosylation pattern.
Closing in on ‘Holy Grail’ of HIV Vaccine
Researchers describe a way to induce long-sought broadly neutralizing antibodies.
Parkinson's Vaccine: EU-Team Launches Clinical Trial
Vaccine candidate based on proprietary technology by AFFiRiS AG.
Injectable 3-D Vaccines Could Fight Cancer
New findings show programmable biomaterials can be delivered using needle injection to induce an immune response and fight deadly diseases.
Booster Ebola Vaccine Enters First Trials
Trials aim to determine the safety of a candidate booster vaccine.
Breast Cancer Vaccine Shows Promise In Small Clinical Trial
A breast cancer vaccine designed by researchers at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer.
NIAID/GSK Experimental Ebola Vaccine Appears Safe, Prompts Immune Response
Results from NIH Phase 1 clinical trial support accelerated development of candidate vaccine.
A Hybrid Vehicle That Delivers DNA
University at Buffalo researchers are developing new technology to improve DNA vaccines. The new transport system for DNA vaccines could help treat HIV, malaria, HPV and other major illnesses.
Themis Bioscience’s Vaccine Against Chikungunya Successful in Phase 1
Results presented at international conferences in Philadelphia and New Orleans.
Novel Cancer Vaccine Approach for Brain Tumors
Researchers unravel the mechanisms behind a novel cancer vaccine for brain tumors, paving the way for further development.
Scroll Up
Scroll Down
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn